Liraglutide alleviates experimental diabetic cardiomyopathy in a PDH-dependent manner
Jordan S. F. Chan(University of Alberta), John R. Ussher(University of Alberta), Kunyan Yang(University of Alberta), Farah Eaton(University of Alberta), Amanda A. Greenwell(University of Alberta), Christina T. Saed(University of Alberta), Indiresh A Mangra-Bala(University of Alberta), Magnus J. Stenlund(University of Alberta), Seyed Amirhossein Tabatabaei Dakhili(University of Alberta), Keshav Gopal(University of Alberta), Sally R Ferrari(University of Alberta)
Cited by 14
Related Papers
Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency
|Cardiovascular Research|2019|195
GIPR Is Predominantly Localized to Nonadipocyte Cell Types Within White Adipose Tissue
|Diabetes|2022|62
Cardiac-Specific Deletion of Pyruvate Dehydrogenase Impairs Glucose Oxidation Rates and Induces Diastolic Dysfunction
|Frontiers in Cardiovascular Medicine|2018|42
The antianginal ranolazine mitigates obesity-induced nonalcoholic fatty liver disease and increases hepatic pyruvate dehydrogenase activity
|JCI Insight|2019|18
Ketone ester administration improves glycemia in obese mice
|American Journal of Physiology-Cell Physiology|2023|18